D03.122 - Melanoma in situ of left lower eyelid, including canthus
ICD-10: | D03.122 |
Short Description: | Melanoma in situ of left lower eyelid, including canthus |
Long Description: | Melanoma in situ of left lower eyelid, including canthus |
Status: | Valid for Submission |
Version: | ICD-10-CM 2023 |
Code Classification: |
D03.122 is a billable ICD-10 code used to specify a medical diagnosis of melanoma in situ of left lower eyelid, including canthus. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
Replacement Code
D03122 replaces the following previously assigned ICD-10 code(s):
- D03.12 - Melanoma in situ of left eyelid, including canthus
Patient Education
Melanoma
Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or "ugly looking."
Thinking of "ABCDE" can help you remember what to watch for:
- Asymmetry - the shape of one half does not match the other
- Border - the edges are ragged, blurred or irregular
- Color - the color is uneven and may include shades of black, brown and tan
- Diameter - there is a change in size, usually an increase
- Evolving - the mole has changed over the past few weeks or months
Surgery is the first treatment of all stages of melanoma. Other treatments include chemotherapy and radiation, biologic, and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Melanoma Summary
Learn about melanoma risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.[Learn More in MedlinePlus]
Skin Cancer (Including Melanoma)-Patient Version
Learn about melanoma risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019